Efficacy of maxillary sinus augmentation using long-term absorbable GBR membrane(GMEM-B2)

MUNAKATA MOTOHIRO0 个研究点目标入组 25 人开始时间: 2019年10月28日最近更新: 2023年10月17日

试验速览

暂无简介。

•1.20 years old or older and less than 65 years old
•2.Non-smoker
•3.Patients with bone mass less than 4 mm planned implant placement site according to CT examination results
•4.Patients obtained written informed consent about participation in this study

•1.Removable prosthetics
•2.Patient with respiratory disease
•3.Osteoporosis, severe diabetes, rheumatoid arthritis, bone metabolism diseases such as taking steroids or BP drugs and those taking medications
•4.Patients with alcohol and drug addiction, mental illness
•5.Patients with cyst or tumor / inflammation in maxillary sinus on CT examination result
•6.Patients who had got the radiation therapy.
•7.Patients with heart disease, blood disease, collagen disease
•8.Patients with kidney failure or dialysis
•9.Patients who are pregnant and lactation period
•10.Patients with a history of hypersensitivity or allergy to copolymer of e-caprolactone and L-lactide
•11.Patients who are judged as improper to join in this study by the principal investigator or co-investigators.

发起方

MUNAKATA MOTOHIRO